Meeting requested to address questions, inform planning for use of remdesivir, the only FDA-authorized drug for COVID-19 treatment.
H.R.6800, the Health Heroes Act, includes policies and investments that would bolster the federal response to COVID-19, increase testing capacity and availability of medical supplies and address the disparate impact of COVID-19 on vulnerable populations.
The U.S. Department of Health and Human Services decision allowing state health departments to distribute limited supplies of remdesivir to treat COVID-19 where they are needed will support fair and equitable access to the drug.
Strong and specific federal guidance is critical to protecting our country, our communities, our health and our lives in the face of the still escalating impacts of COVID-19 across the United States.
With FDA emergency authorization of remdesivir to treat COVID-19, the Infectious Diseases Society of America and its HIV Medicine Association are calling on Vice President Mike Pence and other administration officials to provide public transparency in the process for determining how and where the medication is distributed
With data showing alarmingly high rates of COVID-19 infection among people who are incarcerated, the Infectious Diseases Society of America and its HIV Medicine Association today released policy recommendations to prevent and respond to the spread of the coronavirus in detention settings.
As leading public health and medical organizations, we represent front-line workers and experts who are witnessing the critical importance of maintaining physical distancing measures until data and resources indicate that lifting them is safe.
The Infectious Diseases Society of America and its HIV Medicine Association warned today that prematurely easing social distancing measures put in place to curtail the spread of COVID-19 will risk increased infections and deaths, incapacitated health care facilities, and prolonged economic hardships.
The unprecedented public health crisis of the COVID-19 pandemic demands a comprehensive international response. President Trump’s announcement Tuesday that he will suspend funding to the World Health Organization is against all of our best interests.
IDSA and HIVMA welcome the president's extension of his projected duration for stay-at-home and physical distancing guidelines to last at least through April based on public health guidance, while calling for continued commitment to data-driven responses to the coronavirus.
In the midst of the new global health threat posed by COVID-19, this World TB Day reminds us that global efforts to control the world’s leading infectious disease killer must be accelerated to rid us of our oldest pandemic.
Infectious disease and HIV physicians, healthcare epidemiologists and other medical professionals on the frontlines defending our country from COVID-19 urgently need equipment and supplies to protect themselves, identify infections, treat patients, and save lives.
